BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24134749)

  • 1. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.
    Cust AE; Goumas C; Vuong K; Davies JR; Barrett JH; Holland EA; Schmid H; Agha-Hamilton C; Armstrong BK; Kefford RF; Aitken JF; Giles GG; Bishop D; Newton-Bishop JA; Hopper JL; Mann GJ; Jenkins MA
    BMC Cancer; 2013 Sep; 13():406. PubMed ID: 24134749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.
    Cust AE; Goumas C; Holland EA; Agha-Hamilton C; Aitken JF; Armstrong BK; Giles GG; Kefford RF; Schmid H; Hopper JL; Mann GJ; Jenkins MA
    Int J Cancer; 2012 Aug; 131(3):E269-81. PubMed ID: 22095472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a melanoma risk prediction model incorporating MC1R genotype and indoor tanning exposure: impact of mole phenotype on model performance.
    Penn LA; Qian M; Zhang E; Ng E; Shao Y; Berwick M; Lazovich D; Polsky D
    PLoS One; 2014; 9(7):e101507. PubMed ID: 25003831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoor tanning and the MC1R genotype: risk prediction for basal cell carcinoma risk in young people.
    Molinaro AM; Ferrucci LM; Cartmel B; Loftfield E; Leffell DJ; Bale AE; Mayne ST
    Am J Epidemiol; 2015 Jun; 181(11):908-16. PubMed ID: 25858289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
    Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk Factors.
    Vuong K; Armstrong BK; Weiderpass E; Lund E; Adami HO; Veierod MB; Barrett JH; Davies JR; Bishop DT; Whiteman DC; Olsen CM; Hopper JL; Mann GJ; Cust AE; McGeechan K;
    JAMA Dermatol; 2016 Aug; 152(8):889-96. PubMed ID: 27276088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contributions by MC1R Variants to Melanoma Risk in Males and Females.
    Wendt J; Mueller C; Rauscher S; Fae I; Fischer G; Okamoto I
    JAMA Dermatol; 2018 Jul; 154(7):789-795. PubMed ID: 29898205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
    Kanetsky PA; Panossian S; Elder DE; Guerry D; Ming ME; Schuchter L; Rebbeck TR
    Cancer; 2010 May; 116(10):2416-28. PubMed ID: 20301115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
    Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based Studies.
    Cust AE; Drummond M; Kanetsky PA; ; ; Goldstein AM; Barrett JH; MacGregor S; Law MH; Iles MM; Bui M; Hopper JL; Brossard M; Demenais F; Taylor JC; Hoggart C; Brown KM; Landi MT; Newton-Bishop JA; Mann GJ; Bishop DT
    J Invest Dermatol; 2018 Dec; 138(12):2617-2624. PubMed ID: 29890168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
    Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
    Dwyer T; Stankovich JM; Blizzard L; FitzGerald LM; Dickinson JL; Reilly A; Williamson J; Ashbolt R; Berwick M; Sale MM
    Am J Epidemiol; 2004 May; 159(9):826-33. PubMed ID: 15105175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
    Demenais F; Mohamdi H; Chaudru V; Goldstein AM; Newton Bishop JA; Bishop DT; Kanetsky PA; Hayward NK; Gillanders E; Elder DE; Avril MF; Azizi E; van Belle P; Bergman W; Bianchi-Scarrà G; Bressac-de Paillerets B; Calista D; Carrera C; Hansson J; Harland M; Hogg D; Höiom V; Holland EA; Ingvar C; Landi MT; Lang JM; Mackie RM; Mann GJ; Ming ME; Njauw CJ; Olsson H; Palmer J; Pastorino L; Puig S; Randerson-Moor J; Stark M; Tsao H; Tucker MA; van der Velden P; Yang XR; Gruis N;
    J Natl Cancer Inst; 2010 Oct; 102(20):1568-83. PubMed ID: 20876876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.
    Espinosa P; Pfeiffer RM; García-Casado Z; Requena C; Landi MT; Kumar R; Nagore E
    Eur J Cancer; 2016 Jan; 53():115-24. PubMed ID: 26702765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.
    Vallone MG; Tell-Marti G; Potrony M; Rebollo-Morell A; Badenas C; Puig-Butille JA; Gimenez-Xavier P; Carrera C; Malvehy J; Puig S
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):39-50. PubMed ID: 28950052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype.
    Berlin NL; Cartmel B; Leffell DJ; Bale AE; Mayne ST; Ferrucci LM
    Cancer Epidemiol; 2015 Dec; 39(6):1078-83. PubMed ID: 26381319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
    Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
    Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocortin 1 receptor variants and skin cancer risk.
    Han J; Kraft P; Colditz GA; Wong J; Hunter DJ
    Int J Cancer; 2006 Oct; 119(8):1976-84. PubMed ID: 16721784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.